Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Local control and radiotherapy matter in prostate cancer

Nature Reviews Urology volume 6, pages 250–251 (2009)Cite this article

In a study published in The Lancet, long-term androgen suppression (AS) combined with radiotherapy, compared with AS alone, improved outcomes in patients with locally advanced but nonmetastatic prostate cancer. The combined therapy significantly reduced prostate-cancer-specific deaths at 10 years from 23.9% to 11.9% (P <0.001), and improved overall survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Widmark, A. et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373, 301–308 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Granfors, T., Modig, H., Damber, J. E. & Tomic, R. Long-term follow-up of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone. J. Urol. 176, 544–547 (2006).

    Article  PubMed  Google Scholar 

  3. Bill-Axelson, A. et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J. Natl Cancer Inst. 100, 1144–1154 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bolla, M. et al. Ten year results of long term adjuvant androgen deprivation with goserelin in patients with locally advanced prostate cancer: a phase III EORTC study [Abstract]. Int. J. Radiat. Oncol. Biol. Phys. 72, S30–S31 (2008).

    Article  Google Scholar 

  5. Horwitz, E. M. et al. Ten-year follow-up of radiation therapy oncology protocol 92–02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J. Clin. Oncol. 26, 2497–2504 (2008).

    Article  CAS  PubMed  Google Scholar 

  6. Thompson, I. M. et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296, 2329–2335 (2006).

    Article  CAS  PubMed  Google Scholar 

  7. Thompson, I. M. et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial. J. Urol. 181, 956–962 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bolla, M. et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366, 572–578 (2005).

    Article  PubMed  Google Scholar 

  9. Kuban, D. A. et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 70, 67–74 (2008).

    Article  PubMed  Google Scholar 

  10. Mason, M. et al. Defining the need for local therapy in locally advanced prostate cancer: an appraisal of the MRC PR07 study. Clin. Oncol. (R. Coll. Radiol.) 17, 217–218 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Thanks to Brian J. Goldsmith, M.D., for his editorial assistance.

Author information

Author notes

  1. S. A. Rosenthal, Radiation Oncology Centers, Radiological Associates of Sacramento, 1500 Expo Parkway, Sacramento, CA 95815, USA rosenthals@radiological.com

Authors and Affiliations

  1. Radiation Oncology Centers, Radiological Associates of Sacramento, Sacramento, CA, USA

    Seth A. Rosenthal

Authors
  1. Seth A. Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenthal, S. Local control and radiotherapy matter in prostate cancer. Nat Rev Urol 6, 250–251 (2009). https://doi.org/10.1038/nrurol.2009.56

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2009.56

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing